Vaccinium macrocarponFinding
Vaccinium macrocarpon has no detected effect on fasting blood glucose
no difference foundModerate evidenceFinding
01 · The sentence it was drawn from
“In terms of glycemic indicators, HOMA-IR was investigated in five studies, and the pooled estimates suggested that cranberry significantly reduced HOMA-IR (MD = −0.59; 95% CI: −1.05, −0.14; peffect = 0.01; Figure 4D), whereas cranberry supplementation did not show significant alterations to FBG (MD = −0.09; 95% CI: −0.23, 0.04; peffect = 0.17), HbA1c (MD = −0.16; 95% CI: −0.38, 0.05; peffect = 0.13), and fasting insulin (MD = −1.31; 95% CI: −2.85, 0.22; peffect = 0.09).”
Vaccinium macrocarpon
Fasting blood glucose
no difference found
Effect as reported
−0.09mean difference
CI −0.23 to 0.04
- Who
- Adults aged 18 to 80 in randomized placebo-controlled trials of cranberry supplementation (healthy people and patients with overweight or obesity, diabetes, cardiovascular disease, metabolic syndrome or non-alcoholic fatty liver); pooled estimate
- Dose studied
- Pooled doses: capsules or tablets 144 to 1500 mg/day, powder 9 g/day, juice 240 to 750 mL/day; intervention length 2 weeks to 6 months
Moderate evidencePMID 38542695 · 2024
02 · The study
- Study
- meta-analysis
- Duration
- not reported
Evidence, by strength
- strong
- moderatethis finding
- limited
- very limited
- insufficient
03 · The paper
Nutrients04 · To cite this finding
This address does not changehttps://catalystproject.ai/e/01M6Y1CJC7MZ4FP4J9KK8MC8E1